Motivating high performance in pharmaceutical sales teams is a growing issue in the pharmaceutical industry. The challenges facing the pharmaceutical industry in motivating sales teams are compounded by a variety of factors that many other industries do not face including: government regulation of sales practices‚ non-direct tracking of sales results‚ and the impact of managed care on sales performance. By impacting a few key team process and compensation elements pharmaceutical companies can have a significant
Premium Pharmacology Pharmaceutical drug Pharmacy
RiDUCES and Competitor Analysis Pfizer‚ Inc: Branded Pharmaceutical Industry-Oncology Pharmaceuticals Executive Summary The value that the branded pharmaceutical industry adds to the US economy is growing slower than US GDP (Snyder‚ 2012). Rivalry has intensified while the rate of blockbuster drug development has slowed due to an increase in regulation from the government and the industry trade association‚ PhRMA. The number of new entrants is fairly low and some are exiting or consolidating through
Premium Pharmaceutical industry Pharmacology Novartis
portfolio is to analyze whether Pfizer Inc. is a market leader of producing ethical products in the pharmaceutical industry in Hong Kong. To achieve this objective‚ Pfizer needs to enlarge and rectify their marketing communications‚ (such as‚ adjust their promotional tools‚ differentiate their products...etc). Introduction Pfizer Inc. is established since 1849 by Charles Pfizer and Charles Earhart and up till now‚ it has 150 countries using their pharmaceutical products. The headquarters is located
Premium
| David Messer | 4/29/2013 | | David Messer Jeremy Black Business 220 April 29‚ 2013 GlaxoSmithKline GlaxoSmithKline is a U.K.-based pharmaceutical powerhouse formed by a merger in the late 90’s‚ with the most important merger being that between Glaxo Wellcome and Smith Kline Beecham. The merger created a pharmaceutical industry giant with operations in over 100 countries and annual sales over $25 billion. In the U.S. alone‚ prescription drugs account for 10% of all medical costs
Premium
Ajinomoto Ajinomoto Co. Inc. is a Japanese food and chemical corporation which produces seasonings‚ cooking oils‚ TV dinners‚ sweeteners‚ amino acids and pharmaceuticals. In particular it is the world’s largest producer of aspartame‚ with a 40% global market share. When Professor Kikunae Ikeda from the University of Tokyo isolated glutamate from the seaweed and discovered its flavour enhancing properties in 1908. The next year‚ his discovery was introduced to the market in the form of the flavour
Premium Balance sheet Food processing Food industry
Pharmaceuticals: Merck Sustaining Long-term Advantage Through Information Technology Hiroshi Amari Working Paper No. 161 Working Paper Series Center on Japanese Economy and Business Columbia Business School December 1998 Columbia-Yale Project: Use of Software to Achieve Competitive Advantage PHARMACEUTICALS: MERCK Sustaining Long-term Advantage Through Information Technology Prepared by Hiroshi Amari Research Associate‚ Yale University William V. Rapp and Hugh T. Patrick Co-principal
Premium Clinical trial Pharmaceutical industry Drug development
development ProText Knowledge Services Global Pharmaceutical Market: Overview 1. Indust ry Overview The pharmaceutical industry of the world develops and markets medicines prescribed for patients by medical practitioners. The U.S.‚ U.K and European pharmaceutical companies are the major ones of the industry. The total number of major pharmaceutical companies (annual revenues USD 1‚000 million and above) worldwide The global pharmaceutical industry is estimated to be about 50. This report gives
Premium Pharmaceutical industry Generic drug Drug development
ASSIGNMENT – INTERNAL ASSESSMENT OF PFIZER‚ Inc. Provide a brief description of your company and identify 3 general terms for each of the 6 categories of the value chain which could apply to your organization and explain how they are relevant to this analysis (18 items). Pfizer‚ Inc. is a pharmaceutical corporation with annual revenue of $ 67.8 billion (2010 Annual Report). It is traded on the New York Stock Exchange (NYSE) under the symbol PFE. It is also Dow Jones Component Company. The
Premium Marketing Management Strategic management
Merck: Conflict and change Assessment: Merck is one of the biggest pharmaceutical companies in the world today. Although encountered with success‚ it still faces many problems today while trying to be the market leader competing against its competition. While being research and development driven company‚ Merck now has to go beyond R&D to stay competitive in the pharmaceutical industry. The main issue that seems to come up is that how far
Premium Pharmaceutical industry Pharmacology
developed economies of the world. It is important to take a holistic view of the prevailing policy framework covering generic drugs globally‚ making it possible to analyze the effects of these policies on the generic pharmaceutical industry. The first pertinent area of global pharmaceutical policy is funding of research in life sciences. This pertains primarily to reference drugs rather than generic drugs. Globally‚ there is no overarching framework for the same. This is primarily done only in the
Premium Health care Medicine Health